Maternal opioid exposure during pregnancy

Lire cet article en français

Takeaway

  • Maternal opioid exposure was associated with higher risks of fetal growth restriction; pre-term birth; lack of expected physiological development; conduct disorder/emotional disturbance and diagnosis of attention deficit hyperactivity disorder (ADHD).

Why this matters

  • The rate of opioid use disorder among pregnant women in the US has significantly increased over the past decade, but little is known about the long-term physical and mental health consequences of children exposed to opioids in the womb.

  • Understanding the impact of opioid abuse among pregnant women will help prevent adverse outcomes in their children and will aid in the development of policies and programs to address the growing opioid epidemic.

Vous souhaitez en lire plus ?

Vous souhaitez en lire plus ?

Connectez-vous à votre compte ou inscrivez-vous à Neurodiem pour consulter la suite.

Vous avez déjà un compte ? S'identifier

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.